Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
Analyst Firms Making Recommendations1
- Cantor Fitzgerald
- B of A Securities
- JMP Securities
- HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Kura Oncology
What is the target price for Kura Oncology (KURA)?
The latest price target for Kura Oncology (NASDAQ: KURA) was reported by Cantor Fitzgerald on September 7, 2023. The analyst firm set a price target for $30.00 expecting KURA to rise to within 12 months (a possible 238.60% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kura Oncology (KURA)?
The latest analyst rating for Kura Oncology (NASDAQ: KURA) was provided by Cantor Fitzgerald, and Kura Oncology reiterated their overweight rating.
When is the next analyst rating going to be posted or updated for Kura Oncology (KURA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kura Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kura Oncology was filed on September 7, 2023 so you should expect the next rating to be made available sometime around September 7, 2024.
Is the Analyst Rating Kura Oncology (KURA) correct?
While ratings are subjective and will change, the latest Kura Oncology (KURA) rating was a reiterated with a price target of $0.00 to $30.00. The current price Kura Oncology (KURA) is trading at is $8.86, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.